MFP
TMO icon

Meramec Financial Planners’s Thermo Fisher Scientific TMO Stock Holding History

Meramec Financial Planners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$195K Sell
348
-5
-1% -$2.4K 0.07% 125
2026
Q1 		$186K Buy
353
+1
+0.3% +$543 0.07% 121
2025
Q4 		$191K Buy
+352
New +$199K 0.07% 127

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Meramec Financial Planners's TMO Position: Q2 2026 in Review

Meramec Financial Planners reduced its Thermo Fisher Scientific (TMO) stake by 1.4% in Q2 2026, selling an estimated $2.4K and leaving 348 shares worth $195K. The position accounts for 0.07% of the portfolio, ranked #125.

Meramec Financial Planners first reported a position in TMO in Q4 2025 and has held it in 3 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Meramec Financial Planners held 348 shares of Thermo Fisher Scientific worth $195K as of Q2 2026.
  • Meramec Financial Planners sold 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
  • Thermo Fisher Scientific made up 0.07% of Meramec Financial Planners's portfolio in Q2 2026, its #125 holding.
  • Meramec Financial Planners first reported a position in Thermo Fisher Scientific in Q4 2025 and has held it in 3 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Meramec Financial Planners's 13F filing for Q2 2026, filed 29 Jul 2026.